All sessions are listed in Eastern time
- 7:00 p.m. – 8:00 p.m.
- IO and CN for RCC
Speaker: Jose A. Karam, MD, FACS
- 8:00 p.m. – 9:00 p.m.
- Update on Treatment of Penile Cancer
Speaker: Philippe E. Spiess, MD, MS
Register for Webinar
Jose A. Karam, MD, FACS, is an Associate Professor in the Department of Urology and Department of Translational Molecular Pathology at The University of Texas MD Anderson Cancer Center in Houston, Texas. He received his bachelor’s degree in Biology with Distinction and earned his medical degree with Distinction from the American University of Beirut. Dr. Karam’s primary clinical and research interest is renal cell carcinoma. He is certified by the American Board of Urology, and performs open, laparoscopic, and robotic surgery, individually tailored for the needs of patients with cancers of the kidney, testis and adrenal, with a special interest in surgery for locally advanced and locally recurrent disease. Dr. Karam has a research interest in integration of targeted therapy with surgery, sarcomatoid renal cell carcinoma, rare kidney cancer histologies, mouse models of renal cell carcinoma and molecular markers. He is also involved in clinical trials investigating systemic therapy in the neoadjuvant, presurgical and adjuvant settings. Dr. Karam has authored more than 220 articles, including original research, book chapters, reviews, and invited editorials. He is on the Editorial Boards of Cancer, BJU International, Clinical Genitourinary Cancer, European Urology Oncology, and serves as Section Editor (Urologic Oncology) for Annals of Surgical Oncology, and Associate Editor for Frontiers in Oncology (Genitourinary Oncology), and is a member of the American Urological Association Testicular Cancer Guideline Panel. Dr. Karam is Vice Chair of the Medical Steering Committee and Chair of the Grant Review Committee of the Kidney Cancer Association, and a member of the Programmatic Panel of the US Department of Defense Kidney Cancer Research Program.
Philippe E. Spiess, MD, MS